CV Therapeutics Inc. says the MERLIN TIMI-36 study of ranolazine will proceed to the study close-out phase now that the ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
FDA has accepted ARIXTRA (fondaparinux sodium) Injection for priority review — the anticoagulant supplemental drug ...
October 04, 2006
FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early ...
October 01, 2006Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve ...
September 28, 2006Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart ...
September 26, 2006Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor
Cardiologists were urged to halt the ...
September 18, 2006© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now